McNeill Jonathan bought CBIO
December 15, 2025 · Form 4 insider transaction
McNeill Jonathan bought 78,029 shares of Crescent Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
78,029
Price
$0.00
Total value
N/A
InsiderMcNeill Jonathan
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateDecember 15, 2025
Filing dateDecember 17, 2025
Shares owned after78,029
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This Option represents a right to purchase shares of the Issuer's Ordinary Shares and vests with respect to 1/48th of the Option on each monthly anniversary of December 15, 2025, subject to the Reporting Person remaining continuously employed by or providing services to the Issuer or its subsidiaries from December 15, 2025 through each such vesting date.